BESIFLOXACIN

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C19H21ClFN3O3
Molecular Weight	393.84
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of BESIFLOXACIN

Structure Search

SMILES

N[C@@H]1CCCCN(C1)C2=C(F)C=C3C(=O)C(=CN(C4CC4)C3=C2Cl)C(O)=O

InChI

InChIKey=QFFGVLORLPOAEC-SNVBAGLBSA-N

InChI=1S/C19H21ClFN3O3/c20-15-16-12(18(25)13(19(26)27)9-24(16)11-4-5-11)7-14(21)17(15)23-6-2-1-3-10(22)8-23/h7,9-11H,1-6,8,22H2,(H,26,27)/t10-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C19H21ClFN3O3
Molecular Weight	393.84
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:33:19 UTC 2023` Edited by `admin` on `Fri Dec 15 16:33:19 UTC 2023`
Record UNII	BFE2NBZ7NX
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BESIFLOXACIN

Official Name

English

besifloxacin [INN]

Common Name

English

BESIFLOXACIN [VANDF]

Common Name

English

BESIFLOXACIN [MART.]

Common Name

English

3-QUINOLINECARBOXYLIC ACID, 7-((3R)-3-AMINOHEXAHYDRO-1H-AZEPIN-1-YL)-8-CHLORO-1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-

Common Name

English

(+)-7-((3R)-3-AMINOHEXAHYDRO-1H-AZEPIN-1-YL)-8-CHLORO-1-CYCLOPROPYL-6-FLUORO-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID

Systematic Name

English

BESIFLOXACINE

Common Name

English

BESIFLOXACIN [MI]

Common Name

English

Besifloxacin [WHO-DD]

Common Name

English

ISV-403

Code

English

Classification Tree Code System Code

WHO-VATC

QS01AE08

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

WHO-ATC

S01AE08

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

NCI_THESAURUS

C795

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

WHO-ATC

S01AX23

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

NDF-RT

N0000175937

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

NDF-RT

N0000007606

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

Code System Code Type Description

WIKIPEDIA

Besifloxacin

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

FDA UNII

BFE2NBZ7NX

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

DRUG BANK

DB06771

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

INN

8958

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

PUBCHEM

10178705

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

SMS_ID

100000126378

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

RXCUI

819911

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

RxNorm

EVMPD

SUB33064

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

DRUG CENTRAL

4111

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

NCI_THESAURUS

C83553

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

ChEMBL

CHEMBL1201760

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

EPA CompTox

DTXSID00161706

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

CAS

141388-76-3

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

DAILYMED

BFE2NBZ7NX

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

MESH

C522124

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

MERCK INDEX

m2448

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

Merck Index

LACTMED

Besifloxacin

Created by admin on Fri Dec 15 16:33:19 UTC 2023 , Edited by admin on Fri Dec 15 16:33:19 UTC 2023

PRIMARY

Related Record Type Details


					7506A6J57T

BESIFLOXACIN HYDROCHLORIDE

SALT/SOLVATE -> PARENT

Amount:


					O478WX4004

STAPHYLOCOCCUS AUREUS

TARGET ORGANISM->INHIBITOR

Amount:


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					BT6U234YR2

STREPTOCOCCUS PNEUMONIAE

TARGET ORGANISM->INHIBITOR

Amount:


					RA8G5XH9FW

BACTERIAL DNA GYRASE

TARGET -> INHIBITOR

Amount:


					K738E2MB3I

HAEMOPHILUS INFLUENZAE

TARGET ORGANISM->INHIBITOR

Amount:


					D5T403TNGE

STAPHYLOCOCCUS EPIDERMIDIS

TARGET ORGANISM->INHIBITOR

Amount:

Related Record Type Details


					25YXF8MF3T

3-QUINOLINECARBOXYLIC ACID, 7-(3-AMINOHEXAHYDRO-1H-AZEPIN-1-YL)-1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-, (R)-

METABOLITE -> PARENT

Amount:

Related Record Type Details


					BFE2NBZ7NX

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Tmax	PHARMACOKINETIC				MULTIPLE DOSE ADMINISTRATION

Biological Half-life	PHARMACOKINETIC